The major drivers and restraints affecting the intravascular catheter market are studied in detail in the report. The major segments of the global intravascular catheter market are also examined in detail in the report to provide readers with an accurate overview of the market's granular composition.
The global intravascular catheter market size is expected to exhibit a 9.3% CAGR over the forecast period from 2019 to 2024, according to the latest research report from Market Research Future (MRFR). The global intravascular catheter market is examined in the report in great detail, including a study of the market's major drivers and restraints, the major segments of the intravascular catheter market, and a study of the market's leading players.
The growing prevalence of renal diseases is a major driver for the global intravascular catheter market. Renal diseases have also grown due to the growing prevalence of diabetes around the world, which can be a causative agent in the incidence of renal diseases. Infectious diseases have also grown in prevalence over recent years, leading to a growing demand from the intravascular catheter market.
Leading players in the global intravascular catheter market include Terumo Corporation, Smiths Medical, Medtronic Inc., McKesson Medical Surgical Inc., Johnson & Johnson, Getinge AB, Edwards Life Sciences Corporation, Cook Medical, Coloplast, C. R. Bard Inc., and Boston Scientific Corporation. Major players in the global intravascular catheter market are likely to focus on product developments and innovation in order to increase their share in the intravascular catheter market in the coming years. Geographical expansion by acquiring smaller, regional entities in the market is also likely to be an important tactic for larger players in the intravascular catheter market.
The Americas and Europe dominate the global intravascular catheter market, with the former expected to lead the global charts over the forecast period. The increasing prevalence of diabetes in these two regions is a major driver for the global intravascular catheter market, as diabetes is a major causative agent for renal diseases, which often necessitate the use of intravascular catheters.